glp 1 schizophrenia Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight and other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September GLP-1 Anti-Obesity Rx and Alcohol

[00:36:24] Emily Field: Ill include the link to register in the show notes so you can grab a spot and continue this conversation with me over there

In summary, maintaining stable blood glucose levels relies on two processes working together: the efficient uptake of glucose into the tissues of the body (mostly muscle and fat) and the controlled release of glucose from the liver through a process called gluconeogenesis

To understand the semaglutide family better, read Ozempic vs

Injection site options include: - Back of arm - Belly (stay more than 1-2 inches AWAY from belly button) - Fatty part of thigh Administer the Injection: Most patients feel more comfort pinching the injection site for this step

We have an amazing arsenal of medications today compared to 10 or 15 years ago, including beneficial classes beyond GLP-1s and GLP-1/GIPs, such as Qsymia (phentermine + topiramate), Contrave (naltrexone + bupropion), and metformin